Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Week in Review

Week in Review: GenScript and its Legend Bio Subsidiary Raise $1 Billion from Hillhouse
Week in Review: WHO Close to Approving Global Use for Two China COVID-19 Vaccines
Week in Review: CANbridge Licenses LogicBio's Adeno-Associated Virus for Gene Therapies in $591 Million Deal
Week in Review: Zai Lab Raises $750 Million in Public Offering for In-Licensed/Novel Drugs
Week in Review: Sinopharm Transfers $4.6 Billion in Assets Including two COVID-19 Vaccines
Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021